通过mTOR介导的p62/SQSTM1稳定,为卵巢癌提供了强大的生存机制
Tomohiro Tamura1, Shimpei Nagai2, Kenta Masuda2
1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan; Department of Extended Intelligence for Medicine, The Ishii-Ishibashi Laboratory, Keio University School of Medicine, Tokyo, Japan.
Cancer letters
|February 19, 2025
概括
超过一半的高度血清性癌症患者对当前的治疗方法有抗性. 针对mTOR信号和使用p62作为生物标志物显示出对耐火病例新组合治疗的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 高度血清性癌 (HGSC) 经常表现出对类药物和PARP抑制剂的耐药性,这是由于熟练的同源重组.
- 这种耐药性导致早期死亡,需要新的治疗策略.
研究的目的:
- 研究和PARP抑制剂耐火性HGSC的治疗策略.
- 确定用于预测治疗反应的生物标志物.
主要方法:
- 机器学习分析HGSC患者数据.
- 开发基因工程HGSC有机体模型.
- 研究了RAS/PI3K/mTOR信号通路和p62表达.
主要成果:
- 异常的RAS/PI3K信号与BRCA1/2野生型卵巢癌的预后不佳有关.
- 由mTOR诱导的p62表达升高表明化疗诱导的mTOR-p62-NRF2通路激活.
- 埃弗罗利斯 (mTOR抑制剂) 降低了p62水平,并改善了化疗敏感性.
结论:
- p62是HGSC治疗干预的潜在生物标志物.
- 与常规化疗和mTOR抑制剂的联合治疗为耐火性HGSC提供了一个有希望的策略.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


